Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Class A Ordinary Shares
-
Shares outstanding
-
62.3M
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
42.9M
-
Shares change
-
+907K
-
Total reported value, excl. options
-
$107M
-
Value change
-
-$472K
-
Put/Call ratio
-
0.55
-
Number of buys
-
50
-
Number of sells
-
-24
-
Price
-
$2.50
Significant Holders of Zura Bio Ltd - Class A Ordinary Shares (ZURA) as of Q4 2024
108 filings reported holding ZURA - Zura Bio Ltd - Class A Ordinary Shares as of Q4 2024.
Zura Bio Ltd - Class A Ordinary Shares (ZURA) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.9M shares
of 62.3M outstanding shares and own 68.85% of the company stock.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (4.86M shares), Deep Track Capital, LP (3.28M shares), RA CAPITAL MANAGEMENT, L.P. (3.22M shares), GREAT POINT PARTNERS LLC (3.17M shares), Pfizer Inc (2.97M shares), BlackRock, Inc. (2.71M shares), JPMORGAN CHASE & CO (2.63M shares), BRAIDWELL LP (2.47M shares), Point72 Asset Management, L.P. (2.41M shares), and ADAR1 Capital Management, LLC (2.08M shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.